Crossref
journal-article
Elsevier BV
Experimental Neurology (78)
References
42
Referenced
462
10.1097/00005072-199603000-00001
/ J. Neuropathol. Exp. Neurol. / Neuropathology of Parkinson's disease by Forno (1996)10.1097/00005072-199305000-00001
/ J. Neuropathol. Exp. Neurol. / Pathology and biology of the Lewy body by Pollanen (1993)10.1073/pnas.95.11.6469
/ Proc. Natl. Acad. Sci. USA / alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies by Spillantini (1998)10.1097/00005072-199804000-00006
/ J. Neuropathol. Exp. Neurol. / Protein nitration in Parkinson's disease by Good (1998)-
Giasson, B. I., J. E. Duda, I. V. Murrayet al.Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science290: 985–989.
(
10.1126/science.290.5493.985
) 10.1046/j.1471-4159.1997.69031326.x
/ J. Neurochem. / A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease by Alam (1997)10.1073/pnas.93.7.2696
/ Proc. Natl. Acad. Sci. USA / Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease by Yoritaka (1996)10.1016/S0197-0186(00)00036-X
/ Neurochem. Int. / Nuclear magnetic relaxation dispersion profiles of substantia nigra pars compacta in Parkinson's disease patients are consistent with protein aggregation by Lopiano (2000)10.1038/35086067
/ Nature Rev. Neurosci. / Failure of the ubiquitin-proteasome system in Parkinson's disease by McNaught (2001)-
Voges, D., P. Zwickl, and W. Baumeister. The 26S proteasome: A molecular machine designed for controlled proteolysis. Annu. Rev. Biochem.68: 1015–1068.
(
10.1146/annurev.biochem.68.1.1015
) 10.1016/S0896-6273(01)00177-5
/ Neuron / Cellular defenses against unfolded proteins: A cell biologist thinks about neurodegenerative diseases by Sherman (2001)10.1126/science.1060627
/ Science / Ubiquitination of a new form of α-synuclein by parkin from human brain: Implications for Parkinson's disease by Shimura (2001)10.1038/26652
/ Nature / The ubiquitin pathway in Parkinson's disease by Leroy (1998)10.1126/science.276.5321.2045
/ Science / Mutation in the alpha-synuclein gene identified in families with Parkinson's disease by Polymeropoulos (1997)10.1038/ng0298-106
/ Nature Genet. / Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease by Kruger (1998)10.1002/ana.67
/ Ann. Neurol. / Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation by Spira (2001)10.1074/jbc.274.48.33855
/ J. Biol. Chem. / Degradation of alpha-synuclein by proteasome by Bennett (1999){'key': '10.1006/exnr.2002.8050_RF18', 'first-page': '1', 'article-title': 'alpha-Synuclein metabolism and aggregation is linged to ubiqutin-independent degradation by the proteasome', 'volume': '25504', 'author': 'Tofaris', 'year': '2001', 'journal-title': 'FEBS Lett.'}
/ FEBS Lett. / alpha-Synuclein metabolism and aggregation is linged to ubiqutin-independent degradation by the proteasome by Tofaris (2001)10.1046/j.1471-4159.2001.00474.x
/ J. Neurochem. / Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells by Rideout (2001)10.1038/35081564
/ Nature Rev. Neurosci. / Alpha-synuclein and neurodegenerative diseases by Goedert (2001)10.1093/hmg/10.9.919
/ Hum. Mol. Genet. / Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis by Tanaka (2001)10.1523/JNEUROSCI.21-24-09549.2001
/ J. Neurosci. / Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death by Stefanis (2001)10.1074/jbc.272.20.13437
/ J. Biol. Chem. / Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation by Craiu (1997)10.1006/bbrc.2000.3676
/ Biochem. Biophys. Res. Commun. / Tissue distribution of constitutive proteasomes, immunoproteasomes, and PA28 in rats by Noda (2000)10.1006/jmbi.2001.5285
/ J. Mol. Biol. / 26[?]S Proteasomes function as stable entities by Hendil (2002)10.1002/ana.10101
/ Ann. Neurol. / Protein surveillance machinery in brains with spinocerebellar ataxia type 3: Redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions by Schmidt (2002)10.1097/00005072-199702000-00002
/ J. Neuropathol. Exp. Neurol. / Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly by Ii (1997)10.1093/hmg/10.10.1049
/ Hum. Mol. Genet. / Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release by Jana (2001)10.1074/jbc.271.26.15504
/ J. Biol. Chem. / Degradation of oxidized proteins in K562 human hematopoietic cells by proteasome by Grune (1996)10.1074/jbc.M100142200
/ J. Biol. Chem. / Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion by Bulteau (1999)10.1093/emboj/20.10.2367
/ EMBO J. / A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome by Touitou (2001)10.1016/S0300-9084(01)01250-0
/ Biochimie / Degradation of oxidized proteins by the 20S proteasome by Davies (2001)10.1046/j.1471-4159.1998.70010268.x
/ J. Neurochem. / Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay by Floor (1998)10.1007/978-3-7091-6842-4_9
/ J. Neural Transm. Suppl. / Neuronal vulnerability in Parkinson's disease by Hirsch (1997)10.1016/S0165-3806(01)00181-X
/ Brain Res. Dev. Brain Res. / The expression of mRNAs for the proteasome complex is developmentally regulated in the rat mesencephalon by El-Khodor (2001)10.1136/jnnp.51.6.745
/ J. Neurol. Neurosurg. Psychiatry / The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease by Gibb (1988)10.1074/jbc.M004209200
/ J. Biol. Chem. / Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo by Nam (2001)10.1002/ana.410440712
/ Ann. Neurol. / Understanding cell death in Parkinson's disease by Jenner (1998)10.1111/j.1471-4159.1990.tb05809.x
/ J. Neurochem. / Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease by Schapira (1990)10.1523/JNEUROSCI.20-02-00589.2000
/ J. Neurosci. / Proteasome involvement and accumulation of ubiquitinated proteins in cerebellar granule neurons undergoing apoptosis by Canu (2000)10.1046/j.1471-4159.2002.00821.x
/ J. Neurochem. / Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures by McNaught (2002)10.1097/00001756-200208070-00018
/ NeuroReport / Proteasome inhibition causes nigral degeneration with inclusion bodies in rats by McNaught (2002)
Dates
Type | When |
---|---|
Created | 22 years, 8 months ago (Dec. 30, 2002, 1:11 p.m.) |
Deposited | 1 year, 7 months ago (Jan. 8, 2024, 11:53 a.m.) |
Indexed | 1 hour, 23 minutes ago (Sept. 3, 2025, 5:33 a.m.) |
Issued | 22 years, 8 months ago (Jan. 1, 2003) |
Published | 22 years, 8 months ago (Jan. 1, 2003) |
Published Print | 22 years, 8 months ago (Jan. 1, 2003) |
@article{St_P_McNaught_2003, title={Altered Proteasomal Function in Sporadic Parkinson’s Disease}, volume={179}, ISSN={0014-4886}, url={http://dx.doi.org/10.1006/exnr.2002.8050}, DOI={10.1006/exnr.2002.8050}, number={1}, journal={Experimental Neurology}, publisher={Elsevier BV}, author={St. P. McNaught, Kevin and Belizaire, Roger and Isacson, Ole and Jenner, Peter and Olanow, C.Warren}, year={2003}, month=jan, pages={38–46} }